FDA Approves First Oral Pill for Thalassemia Anaemia

The US FDA has approved a new oral pill called mitapivat, also known as Aqvesme, to treat anaemia in adults with thalassemia.

Thalassemia is a genetic blood disorder that affects the production of healthy red blood cells.

This pill is taken twice a day and can help people who need regular blood transfusions and those who don't.

Doctors say this is a big step forward because it treats the disease at its core, not just the symptoms.

It makes red blood cells stronger and last longer, which means people might need fewer blood transfusions.

The pill is not yet available in India but could be a game-changer for many patients, especially in a country like India where thalassemia is a significant health issue.

Clinical trials have shown good results, and it could also help children with thalassemia.

Making this drug available and affordable in India would be a big help for patients and their families.